迪士尼(DIS.US)電影「黑豹2」及「蟻俠3」獲淮在內地上映
中國陸續放行荷里活電影,迪士尼(DIS.US)旗下漫威影業(Marvel)在微博表示,《黑豹2:瓦干達萬歲》將於2月7日在中國上映,該片約3個月前在全球上映,票房已累計達約8.37億美元。另外,《蟻俠與黃蜂女:量子狂熱》亦將在2月17日在中國上映,與美國預定檔期相若。
中國上月批准迪士尼另一電影《阿凡達:水之道》上映,據貓眼娛樂數據,自去年12月底上映以來,該片在中國的票房收入超過15億元人民幣(折合約2.214億美元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.